Latest news

Thumbnail image for NEJM publishes venetoclax/rituximab data

NEJM publishes venetoclax/rituximab data

A combination of venetoclax and rituximab being developed by AbbVie and Roche/Genentech significantly improved progression-free survival (PFS) in patients with chronic lymphocytic leukaemia (CLL), shows data published by the New England Journal of Medicine.

22nd March 2018

Thumbnail image for US expands scope of Seattle Genetics’ Adcetris

US expands scope of Seattle Genetics’ Adcetris

US regulators have approved Seattle Genetics’ Adcetris in combination with chemotherapy for adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma.

21st March 2018

Thumbnail image for Novartis links with NHS Cancer Vanguard sites

Novartis links with NHS Cancer Vanguard sites

Swiss drug giant Novartis has announced the launch of two new joint working projects with national Cancer Vanguard sites, which aim to determine novel ways of boosting patient care pathways and access to services.

21st March 2018

Thumbnail image for Charity forms Alzheimer’s disease taskforce

Charity forms Alzheimer’s disease taskforce

Alzheimer’s Research UK is calling on the NHS and the pharma industry to join its new taskforce to ensure people with dementia can access future treatments without unnecessary delay.

21st March 2018

Thumbnail image for Skin conditions cost NHS £723m a year

Skin conditions cost NHS £723m a year

New research shows that more than three million primary care hours are spent on skin conditions, at a cost to the NHS of £723 million each year.

21st March 2018

Thumbnail image for NICE rejects rare eye disease drug

NICE rejects rare eye disease drug

Cost regulators for NHS therapies in England and Wales have published draft guidelines rejecting funding for Dompé’s cenegermin as a treatment for neurotrophic keratitis, a rare eye condition.

20th March 2018

Previous  --   3 4 5 6 7 8 9 10 11 12   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download